文献速递其他结缔组织病

I型干扰素特征反映皮肌炎多种表型与活动度指标

The Type I Interferon Signature Reflects Multiple Phenotypic and Activity Measures in Dermatomyositis.
PubMed 文献 · Arthritis Rheumatol · 2023-07-25

研究对202例成人皮肌炎患者的355份全血样本行RNA测序,用13基因I型干扰素评分分析其与器官特异性活动度、自身抗体等的关系。结果显示该评分独立关联肌肉与皮肤活动度、间质性肺病及抗MDA-5抗体,且随时间变化与皮肤或肌肉活动度变化显著相关。

要点

  • I型干扰素评分与肌肉、皮肤活动度、间质性肺病及抗MDA-5抗体独立相关。
  • 抗MDA-5抗体阳性者评分中位数较高,抗Mi-2抗体阳性者较低。
  • 评分变化与皮肤活动度变化高度相关(Spearman ρ=0.84-0.95)。

核心结论

  • I型干扰素评分独立关联皮肌炎皮肤与肌肉活动度及某些临床和血清学特征。
  • 校正肌肉疾病和抗MDA-5状态后,该评分与皮肤活动度强相关,支持I型干扰素阻断作为皮肌炎治疗策略。

研究设计与样本

  • 对202例表型明确的成人皮肌炎患者临床随访期间采集的355份全血样本行RNA测序。
  • 采用既往定义的13基因I型干扰素评分,以横断面和纵向数据建模分析人口学、血清学及临床变量。

主要发现

  • I型干扰素驱动的转录反应模式在各样本间呈刻板化,模块激活顺序与系统性红斑狼疮高度相似。
  • 抗MDA-5抗体阳性患者I型干扰素评分中位数高于无该抗体者,抗Mi-2抗体阳性患者则低于无该抗体者。
  • 绝对I型干扰素评分独立关联肌肉和皮肤疾病活动度、间质性肺病及抗MDA-5抗体。
  • I型干扰素评分随时间的变化与皮肤或肌肉疾病活动度变化显著相关。
  • 分层分析校正器官受累和抗体类别异质性后,评分变化与皮肤活动度变化高度相关(Spearman ρ=0.84-0.95)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The type 1 interferon (IFN) pathway is up-regulated in dermatomyositis (DM). We sought to define how organ-specific disease activity as well as autoantibodies and other clinical factors are independently associated with systemic type I IFN activity in adult patients with DM. METHODS: RNA sequencing was performed on 355 whole blood samples collected from 202 well-phenotyped DM patients followed up during the course of their clinical care. A previously defined 13-gene type I IFN score was modeled as a function of demographic, serologic, and clinical variables using both cross-sectional and longitudinal data. RESULTS: The pattern of type I IFN-driven transcriptional response was stereotyped across samples with a sequential modular activation pattern strikingly similar to systemic lupus erythematosus. The median type I IFN score was higher or lower in patients with anti-melanoma differentiation-associated protein 5 (anti-MDA-5) or anti-Mi-2 antibodies, respectively, compared to patients without these antibodies. Absolute type I IFN score was independently associated with muscle and skin disease activity, interstitial lung disease, and anti-MDA-5 antibodies. Changes in the type I IFN score over time were significantly associated with changes in skin or muscle disease activity. Stratified analysis accounting for heterogeneity in organ involvement and antibody class revealed high correlation between changes in the type I IFN score and skin disease activity (Spearman's ρ = 0.84-0.95). CONCLUSION: The type I IFN score is independently associated with skin and muscle disease activity as well as certain clinical and serologic features in DM. Accounting for the effect of muscle disease and anti-MDA-5 status revealed that the type I IFN score is strongly correlated with skin disease activity, providing support for type I IFN blockade as a therapeutic strategy for DM.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Tabata MM, Hodgkinson LM, Wu TT, et al. The Type I Interferon Signature Reflects Multiple Phenotypic and Activity Measures in Dermatomyositis. Arthritis Rheumatol. 2023. PMID: 37096447. doi:10.1002/art.42526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。